A Prospective, Randomized, Double Blind, Placebo-controlled, Multicenter, Phase 3 Efficacy and Safety Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease


Güldiken Y., Orhan K. S., Polat B., Çelik M., Sönmez S., Aydemir L.

Project Supported by Private Organizations in Other Countries, 2018 - 2020

  • Project Type: Project Supported by Private Organizations in Other Countries
  • Begin Date: August 2018
  • End Date: December 2020